Navigation Links
ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
Date:10/25/2012

SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record results for the quarter ended September 30, 2012. Revenue for the quarter ended September 30, 2012 was $339.7 million, an 8% increase (a 12% increase on a constant currency basis) over the quarter ended September 30, 2011. For the quarter ended September 30, 2012, net income was $71.3 million, an increase of 41% compared to the quarter ended September 30, 2011. Diluted earnings per share for the quarter ended September 30, 2012 were $0.49, a robust 48% increase compared to the quarter ended September 30, 2011.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

SG&A expenses were $98.3 million for the quarter ended September 30, 2012, an increase of $4.1 million, or 4% (a 9% increase on a constant currency basis) compared to the quarter ended September 30, 2011. SG&A costs were 28.9% of revenue in the quarter ended September 30, 2012, compared to 29.9% for the quarter ended September 30, 2011. SG&A expenses were favorably impacted by the depreciation of the Australian dollar and euro against the U.S. dollar.

R&D expenses were $27.2 million for the quarter ended September 30, 2012, or 8.0% of revenue. R&D expenses increased by 4% (a 6% increase on a constant currency basis) compared to the quarter ended September 30, 2011. R&D expenses were favorably impacted by the depreciation of the Australian dollar against the U.S. dollar.

The company amortized acquired intangibles of $2.6 million ($2.0 million, net of tax) during the quarter ended September 30, 2012. Stock-based compensation costs incurred during the quarter ended September 30, 2012 of $7.9 million ($5.9 million, net of tax) consisted of expenses associated with stock options, restricted stock
'/>"/>

SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
2. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
3. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
4. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
5. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
6. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
7. PDI, Inc. Announces New Multi-Year Win Valued At up to $150 Million and Provides Outlook for 2012
8. ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188
9. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
10. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
11. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Bayer Corporation hosted its annual "Take Your Child to Work ... headquarters.  This is Bayer,s second "Take Your Child To Work ... campus, and Thursday,s event welcomed 230 children ready to see ... Fortunately, for the kids, this was not just another ... "Science For A Better Life," Bayer made sure that "Take ...
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
(Date:4/24/2015)... Introduction of new ... tools for radiosurgery/SBRT   The "Elements" ... enhancing the workflow for difficult to treat indications ... - comes full circle with the introduction of ... Elements enable on-the-fly generation of consistent treatment plans ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2
... BOSTON, Dec. 9 Solos Endoscopy, Inc. (Pink Sheets: SNDY) ... sales for the month of October 2009 and $42,898.42 in ... October 2008 and $32,028.52 for November 2008 respectively. , About ... instrument company whose mission is to develop and market breakthrough ...
... , , , GAITHERSBURG, Md, ... in the development and manufacture of lentiviral gene delivery ... Institutes of Health (NIH) small business innovation research (SBIR) ... Generating Hepatitis C Virus-Like Particles using Lentivirus". In ...
Cached Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2
(Date:4/27/2015)... 2015 Final Cut Pro X ... ProTelestrator from Pixel Film Studios. A telestrator is a device ... a moving or still video image. Telestrators are often used ... plays or incoming weather patterns. , After users are done ... the frame slider to control the speed of the animation. ...
(Date:4/27/2015)... PREVENT Life Safety, America’s premier provider of ... the addition of an account manager in Houston. In ... growing customer base, Curtis Rice, an experienced sales professional, ... Manager. Curtis has been added to the team to ... Houston area and beyond. , Curtis brings ...
(Date:4/27/2015)... 2015 Launched by a group ... offered consumers a way to connect to top ... Using a patent-pending Pick Your Price matching algorithm, ... Botox®, laser hair removal and dermal fillers on ... gaps in their schedules. This allows clients to ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 A ... 2015 in the U.S. District Court, Northern District ... ( http://www.testosteronelawsuithub.com/ ) have been consolidated for ... court documents, matters addressed included the intention of ... claims involving their products on preemption grounds, with ...
(Date:4/26/2015)... 26, 2015 Indiana Fiber Network, LLC ... that Brotherhood Mutual Insurance Company has selected IFN as ... Network Infrastructure at Brotherhood Mutual Insurance Company states: “IFN’s ... reliability Brotherhood Mutual needed. We were interested ... worked with us to ensure we achieved both. ” ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:ZendyBeauty Is Pleased to Announce the Expansion and Rebranding of the Company as ZendyHealth.com 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3
... ... on Allied Health Personnel in Ophthalmology (JCAHPO), and the Association of Technical Personnel in ... A Clinical Skills and Reference Guide for the Ophthalmic Technician. , ... St. Paul, MN (Vocus) November ...
... Asher, MD, FACS, of Carolina Neurosurgery & Spine Associates ... treatment guidelines for brain metastases patients. These guidelines were ... Annual Meeting in New Orleans, and were developed over ... medical specialties. Members of the panel analyzed 25,000 brain ...
... Nov. 10 Roxane Laboratories, Inc. announced today the ... Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the ... available in bottles of 100 for immediate shipment to ... Tablets are AB rated to ACEON® (perindopril erbumine) tablets. ...
... be questionable, expert says , TUESDAY, Nov. 10 (HealthDay ... reduce the incidence of gallstones and the need for ... new study indicates. , "We,re talking about people who ... Susan S. Jick, director of the Boston Collaborative Drug ...
... rate of nearly 1 in 4 people , TUESDAY, Nov. ... on Medicare who are hospitalized for heart failure are back ... study reveals. , That should not be happening, said Dr. ... medicine at the Mount Sinai School of Medicine in New ...
... tumours in 50% of mice in a new study published today ... drug also stopped lung cancer tumours from growing and becoming resistant ... are now planning to take the drug into clinical trials, to ... form of lung cancer. One in five people with lung ...
Cached Medicine News:Health News:JCAHPO/ATPO Pocket Guide Launches for Eye Care Professionals 2Health News:JCAHPO/ATPO Pocket Guide Launches for Eye Care Professionals 3Health News:Local Neurosurgeon Co-Authors National Treatment Guidelines for Brain Tumor Patients 2Health News:Roxane Laboratories, Inc. Announces the Launch of Perindopril Erbumine Tablets 2Health News:Statins May Stave Off Gallstones 2Health News:Statins May Stave Off Gallstones 3Health News:The Revolving Door of Heart Failure Hospitalization 2Health News:The Revolving Door of Heart Failure Hospitalization 3Health News:Drug shrinks lung cancer tumors in mice 2Health News:Drug shrinks lung cancer tumors in mice 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 9 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 8.7 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 9.0 mm and length 7.5 mm....
Medicine Products: